584 related articles for article (PubMed ID: 24274865)
1. Obesity and NAFLD: the role of bacteria and microbiota.
Duseja A; Chawla YK
Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
Li DY; Yang M; Edwards S; Ye SQ
JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
[TBL] [Abstract][Full Text] [Related]
3. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
4. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
Miura K; Ohnishi H
World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
[TBL] [Abstract][Full Text] [Related]
5. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.
Iacono A; Raso GM; Canani RB; Calignano A; Meli R
J Nutr Biochem; 2011 Aug; 22(8):699-711. PubMed ID: 21292470
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and nonalcoholic fatty liver disease.
Machado MV; Cortez-Pinto H
Ann Hepatol; 2012; 11(4):440-9. PubMed ID: 22700625
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and non-alcoholic fatty liver disease: new insights.
Aron-Wisnewsky J; Gaborit B; Dutour A; Clement K
Clin Microbiol Infect; 2013 Apr; 19(4):338-48. PubMed ID: 23452163
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatohepatitis: a microbiota-driven disease.
Moschen AR; Kaser S; Tilg H
Trends Endocrinol Metab; 2013 Nov; 24(11):537-45. PubMed ID: 23827477
[TBL] [Abstract][Full Text] [Related]
11. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
[TBL] [Abstract][Full Text] [Related]
12. Role of gut microbiota: obesity and NAFLD.
Gangarapu V; Yıldız K; Ince AT; Baysal B
Turk J Gastroenterol; 2014 Apr; 25(2):133-40. PubMed ID: 25003671
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Escobedo G; López-Ortiz E; Torres-Castro I
Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
[TBL] [Abstract][Full Text] [Related]
14. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.
Xue L; He J; Gao N; Lu X; Li M; Wu X; Liu Z; Jin Y; Liu J; Xu J; Geng Y
Sci Rep; 2017 Mar; 7():45176. PubMed ID: 28349964
[TBL] [Abstract][Full Text] [Related]
15. The role of the gut microbiota in nonalcoholic fatty liver disease.
Abu-Shanab A; Quigley EM
Nat Rev Gastroenterol Hepatol; 2010 Dec; 7(12):691-701. PubMed ID: 21045794
[TBL] [Abstract][Full Text] [Related]
16. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.
Ferolla SM; Armiliato GN; Couto CA; Ferrari TC
Nutrients; 2014 Dec; 6(12):5583-99. PubMed ID: 25479248
[TBL] [Abstract][Full Text] [Related]
17. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
19. Innate sensors of pathogen and stress: linking inflammation to obesity.
Jin C; Flavell RA
J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and its possible relationship with obesity.
DiBaise JK; Zhang H; Crowell MD; Krajmalnik-Brown R; Decker GA; Rittmann BE
Mayo Clin Proc; 2008 Apr; 83(4):460-9. PubMed ID: 18380992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
